a developer of peptide therapeutics for metabolic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, RYTM has been loosely correlated with RCKT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RYTM jumps, then RCKT could also see price increases.
Ticker / NAME | Correlation To RYTM | 1D Price Change % | ||
---|---|---|---|---|
RYTM | 100% | +0.02% | ||
RCKT - RYTM | 48% Loosely correlated | -2.16% | ||
IDYA - RYTM | 43% Loosely correlated | +3.41% | ||
PLRX - RYTM | 43% Loosely correlated | +3.16% | ||
ERAS - RYTM | 42% Loosely correlated | +2.34% | ||
DNLI - RYTM | 42% Loosely correlated | +1.39% | ||
More |